Fenoterol is a β2-adrenergic receptor agonist and bronchodilator medication used in the treatment of asthma. Fenoterol is produced and sold by Boehringer Ingelheim as Berotec N and in combination with ipratropium as Berodual N. It was patented in 1962 and came into medical use in 1971, but in the 1980s concerns emerged about its safety and its use being associated with an increased risk of death. Adverse effects. Fenoterol is a short-acting β2 agonist that also stimulates β1 receptors. Fenoterol has more cardiovascular toxicity than isoprenaline or salbutamol.
https://en.wikipedia.org/wiki/Fenoterol
Fenoterol is a β2-adrenergic receptor agonist and bronchodilator medication used in the treatment of asthma. Fenoterol is produced and sold by Boehringer Ingelheim as Berotec N and in combination with ipratropium as Berodual N. It was patented in 1962 and came into medical use in 1971, but in the 1980s concerns emerged about its safety and its use being associated with an increased risk of death. Adverse effects. Fenoterol is a short-acting β2 agonist that also stimulates β1 receptors. Fenoterol has more cardiovascular toxicity than isoprenaline or salbutamol.
